A new Stanford Medicine-led study found that, with a gradual personalized approach, about half of chronic pain patients cut their opioid use by at least 50% in a year without increased pain. Doses were reduced no more than 10% per month, and patients could control the pace of their taper and pause the taper in collaboration with their clinician.


